Friday, February 17th, 2017 the Brazilian regulatory agency Agencia Nacional da Vigilancia Sanitaria (ANVISA) suspended sales of Bayer's Essure Birth Control.
The banning of Essure by the ANVISA is a tremendous deal!
What does Brazil deem unfit for sales of Essure that the United States has not? That is the question you should be asking.
Once news broke about this development, many legal firms scrambled to find out more.
ANVISA has categorized the device as a maximum risk due to the following side effects:
- Changes in menstrual bleeding
- Unwanted pregnancy
- Chronic pain
- Perforation/migration of the device
- Allergy and sensitivity or immune-type reactions
Resources To View More About This Ban In Brazil
Daily Hornet: Article
WRIC Channel 8 Video
Image via Unsplash